-
January 30, 2012
Second exam important in child sex-abuse cases
NEW YORK (Reuters Health) - When a child is thought to have been sexually abused, a second medical exam may be key to picking up injuries and sexually transmitted infections, a study published Monday finds.
-
January 2, 2012
Some girls overestimate HPV vaccine protection
CHICAGO (Reuters) - Some adolescent girls who get the HPV vaccine to prevent cervical cancer wrongly think they no longer need to practice safe sex, U.S. researchers said on Monday.
-
December 28, 2011
FDA warns docs on wart remover and eye salve mix-ups
-
November 25, 2011
UK switches to Merck's Gardasil for HPV vaccination
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
-
October 25, 2011
US advisers recommend Gardasil HPV shots for boys
CHICAGO (Reuters) - U.S. vaccine advisers on Tuesday voted to recommend that boys be routinely vaccinated with Merck & Co's Gardasil vaccine to protect them from human papillomavirus or HPV infections, which cause genital warts and oral, penile and anal cancers in males and cervical cancers in women.
-
October 19, 2011
US health panel cautious on HPV screening vs Pap
WASHINGTON (Reuters) - A U.S. government-backed medical panel on Wednesday took a cautious view of a new generation of cervical cancer tests, discouraging women under the age of 30 to screen for human papillomavirus as a way to prevent cancer.
-
October 18, 2011
Girls' HPV vaccination rates falling short
NEW YORK (Reuters Health) - Close to half of U.S. girls ages 13 and 17 have gotten at least one dose of the vaccine against human papillomavirus (HPV), but there is still a way to go to improve those numbers, according to researchers at the Centers for Disease Control and Prevention (CDC).
-
October 17, 2011
HPV test more sensitive than Pap, questions remain
NEW YORK (Reuters Health) - Testing women for human papillomavirus (HPV) may catch more pre-cancerous growths than standard cervical cancer screening does -- but more evidence is needed before the newer tests become routine, a study published Monday concludes.
-
October 3, 2011
Virus to blame for rise throat cancer: study
NEW YORK (Reuters Health) - Cancer of the back of the mouth and throat is on the rise, primarily because of more cases stemming from a viral infection called human papillomavirus (HPV), researchers report in a new study.
-
September 5, 2011
More U.S. youth getting recommended vaccines
NEW YORK (Reuters Health) - More and more American adolescents are getting recommended vaccines, according to a survey by the Centers for Disease Control and Prevention (CDC) out Monday.
-
July 4, 2011
Too many women get HPV tests: study
NEW YORK (Reuters Health) - Doctors are testing women for human papillomavirus, or HPV, more often than guidelines recommend, suggests a new study.
-
June 17, 2011
Fewer cervical abnormalities after HPV vaccine
HONG KONG (Reuters) - A vaccine to prevent cervical cancer, triggered by the human papillomavirus (HPV), has helped reduce the number of teenage girls developing abnormalities in their cervix by as much as 50 percent in a study in Australia, researchers reported on Friday.
-
February 11, 2011
Second-hand smoke ups risk of abnormal Pap test
NEW YORK (Reuters Health) - Another reason second-hand smoke is bad: there's a chance it can damage the tissues in a woman's cervix, putting her at higher risk for cervical cancer, a new study suggests.
-
January 7, 2011
Circumcision helps stop wart virus, study finds
WASHINGTON (Reuters) - Researchers have documented yet another health benefit for circumcision, which can protect men against the AIDS virus, saying it can protect their wives and girlfriends from a virus that causes cervical cancer.
-
November 17, 2010
US panel positive on Merck vaccine for anal cancer
SILVER SPRING, Md. (Reuters) - Merck & Co's Gardasil vaccine appears effective for preventing anal cancer, members of a U.S. advisory panel said on Wednesday.
-
October 28, 2010
Experts wrestle with vaccinating boys for HPV
CHICAGO (Reuters) - U.S. vaccine advisers are weighing whether boys and young men should be vaccinated against the human wart virus that causes a number of cancers, but some worry the vaccine is too costly to justify its use.
-
August 23, 2010
Ob/gyn group backs HPV vaccines for 11-12 year olds
NEW YORK (Reuters Health) - Girls between the ages of 11 and 12 should be vaccinated against the human papillomavirus (HPV) before they become sexually active, according to recommendations released Monday by the American College of Obstetricians and Gynecologists (ACOG).
-
July 16, 2010
Consistent condom use may cut men's HPV risk
NEW YORK (Reuters Health) - Men who use condoms every time they have sex are less likely to harbor the virus that causes genital warts than those who are less consistent about protection, a new study finds.
-
October 21, 2009
US advisers decline to push Gardasil for boys
WASHINGTON (Reuters) - U.S. vaccine advisers on Wednesday declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead for "permissive" use.
-
October 20, 2009
Free HPV vaccine curbs new cases of genital warts
NEW YORK (Reuters Health) - Since 2007, when free vaccination against HPV for young women became available, Australia has seen a rapid decline in new cases of genital warts, researchers say. HPV, or human papillomavirus, causes genital warts and cervical cancer.
-
October 9, 2009
Giving Gardasil to boys not cost effective: study
CHICAGO (Reuters) - Vaccinating boys against the virus that causes cervical cancer and genital warts does not appear to be cost-effective, U.S. researchers said on Thursday.
-
September 10, 2009
U.S. panel backs HPV vaccine for males
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday.
-
September 9, 2009
US FDA panel backs Glaxo cervical cancer vaccine
GAITHERSBURG, Md.(Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday.
-
September 4, 2009
Gardasil vaccine seems okay for men: FDA
WASHINGTON (Reuters) - Merck & Co's Gardasil vaccine appears to be safe and effective in preventing genital warts in young men and boys, a U.S. medical reviewer said in documents released on Friday.
-
August 25, 2009
Virus blamed for half of penile cancers
LONDON (Reuters) - A sexually transmitted virus that causes cervical cancer is also to blame for half of all cases of cancer of the penis, Spanish researchers said on Tuesday.
-
August 18, 2009
US researchers see few serious reactions to HPV vaccine
WASHINGTON (Reuters) - Adverse events like fainting or nausea remain rare among young women and girls given Merck and Co's Gardasil vaccine against cervical cancer, U.S. researchers reported on Tuesday.
-
July 23, 2009
Vaccine struggle embodies U.S. health reform battle
WASHINGTON (Reuters) - The confusion surrounding adult vaccination help illustrates some of the big problems looming for Congress as it struggles with healthcare reform legislation, doctors and health officials said on Wednesday.
-
July 6, 2009
HPV shot too costly for the Netherlands: study
NEW YORK (Reuters Health) - The vaccine against the virus responsible for most cases of cervical cancer would have to be a lot cheaper in order for it to be cost effective in the Netherlands, and probably in other countries where cases of cervical cancer and deaths due to the disease are relatively low, Dutch researchers report.
-
June 2, 2009
Cervical cancer vaccine benefits older women: study
WASHINGTON (Reuters) - Older women can benefit just as much as younger women from Merck's Gardasil vaccine against cervical cancer, researchers in Colombia reported on Monday.
-
May 19, 2009
Number of UK children with sex diseases soars
LONDON (Reuters Life!) - The number of British children being diagnosed with sexually transmitted infections (STIs) has soared in recent years, according to government figures.
-
April 2, 2009
Qiagen virus test cuts deaths from cervical cancer
BOSTON (Reuters) - A single test that looks for the virus that causes cervical cancer cut the death rate from the tumor in half, researchers in India reported on Wednesday.
-
March 26, 2009
Male circumcision cuts risk of cancer-causing virus
LONDON (Reuters) - Circumcision protects men from genital herpes and a virus that causes genital warts and cancer but it does not appear to guard against syphilis, U.S. and Ugandan researchers said on Wednesday.
-
March 23, 2009
Circumcision protects against genital wart virus
NEW YORK (Reuters Health) - A study of nearly 1000 men in three countries has yielded more evidence that circumcision helps protect against infection with human papillomavirus.
-
December 19, 2008
Indonesia's "tree man" faces new operations
TANJUNG JAYA, Indonesia (Reuters) - An Indonesian man dubbed the "tree man" because of the gnarled warts all over his body said on Friday his condition had worsened again although he still hoped to recover and find a job.
-
December 18, 2008
Male circumcision lowers cervical cancer risk: study
WASHINGTON (Reuters) - Three studies published on Wednesday add to evidence that circumcision can protect men from the deadly AIDS virus and the sexually transmitted virus that causes cervical cancer.
-
December 3, 2008
Allergic reactions to Gardasil uncommon: study
LONDON (Reuters) - A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses, Australian researchers said on Wednesday.
-
November 13, 2008
Cervical cancer vaccine can protect men from HPV
WASHINGTON (Reuters) - A vaccine designed to protect women and girls from cervical cancer caused by a virus that also causes genital warts may protect men, too, maker Merck and Co reported on Thursday.
-
November 3, 2008
Wart virus caused 25,000 cancers in 5 years
WASHINGTON (Reuters Life!) - The human wart virus HPV caused 25,000 cases of cancer in the United States between 1998 and 2003, including not only cervical cancer but also anal and mouth cancers, the U.S. Centers for Disease Control and Prevention reported on Monday.
-
October 27, 2008
Aggressive vaccine effort could cut cervical cancer
CHICAGO (Reuters) - An aggressive strategy of vaccinating older women against cervical cancer could deliver a crippling blow against the disease, cutting rates for that type of cancer in half for women through age 45, U.S. researchers said on Saturday.
-
October 24, 2008
British doctor chooses Gardasil shot over Cervarix
LONDON (Reuters) - Even though Britain chose GlaxoSmithKline's Cervarix for its cervical cancer vaccine program, many British doctors pick Merck and Co's Gardasil for their own daughters, a well-known physician said on Friday.
-
October 10, 2008
HPV infection rates similar in men and women
NEW YORK (Reuters Health) - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.
-
October 9, 2008
Quarter of adolescent U.S. girls received HPV
WASHINGTON (Reuters) - A quarter of girls aged 13 to 17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.
-
September 2, 2008
All types of sexual activity carry some STD risk
NEW YORK (Reuters Health) - Sexual activity other than intercourse carries some risk of sexually transmitted disease, and doctors should make sure their patients understand that, according to the American College of Obstetricians and Gynecologists (ACOG).
-
September 1, 2008
Study finds more allergic reactions after HPV jab
CHICAGO (Reuters) - Young women in Australia who got a vaccine to prevent cervical cancer were five to 20 times more likely to have a rare but severe allergic reaction than girls who got other vaccines in comparable school-based vaccination programs, researchers said on Monday.
-
July 22, 2008
FDA, CDC say Merck's Gardasil shot remains safe
WASHINGTON (Reuters) - A review of health problems reported after women and girls received Merck & Co's Gardasil vaccine shows it remains safe and effective for protecting against infection with a virus that causes cervical cancer, U.S. officials said on Tuesday.
-
July 15, 2008
Regular chlamydia tests urged for young people
LONDON (Reuters) - Young sexually active people should get themselves tested annually for the infection chlamydia and again every time they change partner, the Health Protection Agency said on Tuesday.
-
June 25, 2008
Merck cancer vaccine not cleared for older women
NEW YORK (Reuters) - U.S. regulators have told Merck & Co they cannot yet approve Merck's application to expand marketing of its cervical cancer vaccine Gardasil to an older group of women, the drugmaker said on Wednesday.
-
June 6, 2008
Green tea extract useful for genital warts
NEW YORK (Reuters Health) - A botanical ointment containing sinecatechins, a green tea extract, is an effective and well tolerated treatment for external genital and anal warts, results of a controlled study confirm.
-
May 21, 2008
Cancer risk soars in HIV-infected people: study
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
-
May 9, 2008
Mom's infection may boost epilepsy risk in offspring
NEW YORK (Reuters Health) - Exposure to certain maternal infections in the womb increases the odds of epilepsy in childhood, according to an analysis of data from a Danish study. Among the infections cited were cystitis (inflammation of the bladder), pyelonephritis (inflammation of the kidney and upper urinary tract), and vaginal yeast infection.